Showing 41-50 of 54 results for "".

• Recent Developments

  https://practicaldermatology.com/columns/recent-developments/recent-developments-38/23774/
  • Text

• Pregnancy and Melanoma: What We Know About the Risks

  https://practicaldermatology.com/topics/practice-management/pregnancy-and-melanoma-what-we-know-about-the-risks/21041/
  Against a backdrop of conflicting findings, a new study suggests a significant risk associated with melanoma during pregnancy.
  • Text

• Which Probiotic for Which Disease? Part 1

  https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/
  Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.
  • Text

• Is Irritable Bowel Linked to Irritable Skin?

  https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/
  Exploring irritable bowel syndrome’s link to dermatologic conditions.
  • Text

• The ABCDEs of AI for Skin Cancer Detection

  https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-abcdes-of-ai-for-skin-cancer-detection/23695/
  Key considerations for dermatologists as AI continues to expand.
  • Text

• Therapeutic Advances in the Topical Management of Acne

  https://practicaldermatology.com/issues/supplements/therapeutic-advances-in-the-topical-management-of-acne/21618/
  • Text

• New Products and Pharmacologic Developments

  https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21633/
  • Text
• CSF Unveils New Faculty, Sessions for 2014 Meeting
  https://practicaldermatology.com/news/20140724-csf_unveils_new_faculty_sessions/2459158/
  Cosmetic Surgery Forum has added new faculty members and educational sessions to its agenda. New to the podium this year will be Joel Cohen, MD, Ellen Marmur, MD, Gerald Goldberg, MD, Michael Greenberg, MD, Sabrina Fabi, MD, and Laurin Council, MD. New sessions include "Polishing Your Neurotoxin Tec
• New Retinoid Foam Wins FDA Approval
  https://practicaldermatology.com/news/20120514-new_retinoid_foam_wins_fda_approval/2459805/
  The FDA has approved Fabior (tazarotene) Foam, 0.1%, for the treatment of acne vulgaris in patients 12 years and older. The approval was based on two multi-center, randomized, double-blind, vehicle-controlled pivotal Phase 3 studies, in which a total of 1,485 patients with moderate-to-severe acne vu
• Sabrina Fabi, MD
  https://practicaldermatology.com/profiles/sabrina-fabi-md/jl94Nn/

• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• Next